USD10
ANVS Shares
About Annovis BioAnnovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.
USD10
ANVS Shares
About Annovis BioAnnovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$74.32M
OPEN PRICE
$1.81
LOW (1Y)
$1.54
HIGH (1Y)
$5.50
LOW (24H)
$1.70
HIGH (24H)
$1.81
VOLUME (24H)
$354.94K
8.81%
Price history
Time | Price | Change |
|---|---|---|
Today | $1.81 | |
1 Day | $1.75 | |
1 Week | $1.71 | |
1 Month | $1.87 | |
1 Year | $2.68 |
Past performance is not a reliable indicator of future results.
Discover more
Explore other stocks
Popular cryptocurrencies
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.
